All news

Robeco trims Regeneron stake by 12.5% in third quarter

Alpha Vantage · MarketBeat · · AI-summarised by FinFlash

Robeco Institutional Asset Management cut its Regeneron Pharmaceuticals stake by 12.5% in the third quarter, selling 57,644 shares and holding 402,958 shares worth $305.6 million. Institutions still own 83.31% of the company, and analysts hold a Moderate Buy consensus with an average price target of $845.59.

Read original source

REGN company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.